Patents by Inventor Lea SCHROEDER

Lea SCHROEDER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cancer therapy with a parvovirus combined with a BCL-2 inhibitor
    Patent number: 10406185
    Abstract: Described is a pharmaceutical composition comprising (a) a parvovirus and (b) an Bcl-2 inhibitor and the use of said composition for treatment of cancer, e.g., a solid tumor. Preferred inhibitors are the BH3 mimetics ABT-737 and ABT-199.
    Type: Grant
    Filed: December 28, 2017
    Date of Patent: September 10, 2019
    Assignees: DEUTSCHES KREBSFORSCHUNGSZENTRUM, RUPRECHT-KARLS-UNIVERSITAT HEIDELBERG
    Inventors: Antonio Marchini, Junwei Li, Lea Schroeder, Jean Rommelaere, Karsten Geletneky
  • CANCER THERAPY WITH A PARVOVIRUS COMBINED WITH A BCL-2 INHIBITOR
    Publication number: 20180117104
    Abstract: Described is a pharmaceutical composition comprising (a) a parvovirus and (b) an Bcl-2 inhibitor and the use of said composition for treatment of cancer, e.g., a solid tumor. Preferred inhibitors are the BH3 mimetics ABT-737 and ABT-199.
    Type: Application
    Filed: December 28, 2017
    Publication date: May 3, 2018
    Inventors: Antonio MARCHINI, Junwei LI, Lea SCHROEDER, Jean ROMMELAERE, Karsten GELETNEKY
  • Cancer therapy with a parvovirus combined with a Bcl-2 inhibitor
    Patent number: 9889169
    Abstract: Described is a pharmaceutical composition comprising (a) a parvovirus and (b) an Bcl-2 inhibitor and the use of said composition for treatment of cancer, e.g., a solid tumor. Preferred inhibitors are the BH3 mimetics ABT-737 and ABT-199.
    Type: Grant
    Filed: December 7, 2015
    Date of Patent: February 13, 2018
    Assignees: DEUTSCHES KREBSFORSCHUNGSZENTRUM, RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG
    Inventors: Antonio Marchini, Junwei Li, Lea Schroeder, Jean Rommelaere, Karsten Geletneky
  • CANCER THERAPY WITH A PARVOVIRUS COMBINED WITH A BCL-2 INHIBITOR
    Publication number: 20160082056
    Abstract: Described is a pharmaceutical composition comprising (a) a parvovirus and (b) an Bcl-2 inhibitor and the use of said composition for treatment of cancer, e.g., a solid tumor. Preferred inhibitors are the BH3 mimetics ABT-737 and ABT-199.
    Type: Application
    Filed: December 7, 2015
    Publication date: March 24, 2016
    Inventors: Antonio MARCHINI, Junwei LI, Lea SCHROEDER, Jean ROMMELAERE, Karsten GELETNEKY